NovaLead Pharma commences Phase 3 Clinical Trial of Its Novel Topical Drug Galnobax for DFU Press Trust of India Aug 29, 2019 Subject to satisfactory completion of Phase 3 trial, Galnobax can be a path-breaking treatment for Diabetic Foot Ulcer (DFU)
